alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › phospho-tau

phospho-tau

7 studies tagged phospho-tau, dated 2001-01-01 to 2024-02-12. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study 2024-02-12
  2. Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals 2023-04-01
  3. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification 2020-03-17

Studies

7 studies carry this tag.

Date range

2001 to 2024

Top journals

  • Alzheimer's research & therapy 2
  • Brain : a journal of neurology 1
  • Journal of neurochemistry 1
  • Neurology 1
  • Neuroscience letters 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer's research & therapy 2024-02-12 Biomarkers

    Considering renal function and age is crucial when interpreting AD biomarkers in the general aging population.

  2. Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Brain : a journal of neurology 2023-04-01 Biomarkers

    The A+P+T- group showed a slower rate of increase in tau-PET compared to the A+P+T+ group, primarily in neocortical regions.

  3. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Alzheimer's research & therapy 2020-03-17 Tau biomarkers

    Increased cerebrospinal fluid pT217 levels, more than those of pT181, are highly specific biomarkers for detecting both the preclinical and advanced forms of Alzheimer's disease.

  4. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Neurology 2018-03-07 Biomarkers

    NfL and p/t-tau similarly discriminated FTD from controls, but not between clinical subtypes, apart from FTD-MND.

  5. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. PLoS genetics 2010-09-16 Genetics

    Alzheimer's Disease (AD) is a complex and multifactorial disease.

  6. Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurochemistry 2007-01-24 Tau biomarkers

    Neurochemical dementia diagnostics (NDD) can significantly improve the clinically based categorization of patients with early dementia disorders, and the cerebrospinal fluid (CSF) concentrations of amyloid beta peptides ending at the amino acid position of 42 (A beta x-42 and A beta 1-42) are widely accepted biomarkers of Alzheimer's disease (AD).

  7. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Neuroscience letters 2001-01-01 Tau biomarkers

    An increase in cerebrospinal fluid (CSF)-total-tau, and recently also in CSF-phospho-tau, has been found in Alzheimer's disease (AD).

All topic tags with their study counts